Clinical Trial Details
— Status: Recruiting
Administrative data
NCT number |
NCT04358198 |
Other study ID # |
RP018 |
Secondary ID |
|
Status |
Recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
May 1, 2020 |
Est. completion date |
February 28, 2024 |
Study information
Verified date |
March 2022 |
Source |
King Chulalongkorn Memorial Hospital |
Contact |
Rapat Pittayanon, MD |
Phone |
66804224999 |
Email |
rapat125[@]gmail.com |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
This study will use artificial intelligence (AI) for diagnosing gastric intestinal
metaplasia.
Description:
The patients with previously diagnose gastric intestinal metaplasia (GIM) and have the
surveillance gastroscopy will be enrolled. The routine surveillance program will be performed
additional to taking photo at both GIM and normal mucosa at least 5 pictures in each. Biopsy
will be done to confirm the diagnosis of GIM and normal mucosa. All pictures will be inserted
to AI algorithm based on the convolutional neural network (CNN). Then, the AI program will be
validated in daily endoscopy compared with pathology. Accuracy, sensitivity and specificity
can be calculated by 2x2 table.